Cargando…
Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia
INTRODUCTION: In this multicenter study on subjective cognitive decline (SCD) in community-based and memory clinic settings, we assessed the (1) incidence of Alzheimer’s disease (AD) and non-AD dementia and (2) determinants of progression to dementia. METHODS: Eleven cohorts provided 2978 participan...
Autores principales: | Slot, Rosalinde E. R., Sikkes, Sietske A. M., Berkhof, Johannes, Brodaty, Henry, Buckley, Rachel, Cavedo, Enrica, Dardiotis, Efthimios, Guillo-Benarous, Francoise, Hampel, Harald, Kochan, Nicole A., Lista, Simone, Luck, Tobias, Maruff, Paul, Molinuevo, José Luis, Kornhuber, Johannes, Reisberg, Barry, Riedel-Heller, Steffi G., Risacher, Shannon L., Roehr, Susanne, Sachdev, Perminder S., Scarmeas, Nikolaos, Scheltens, Philip, Shulman, Melanie B., Saykin, Andrew J., Verfaillie, Sander C. J., Visser, Pieter Jelle, Vos, Stephanie J. B., Wagner, Michael, Wolfsgruber, Steffen, Jessen, Frank, van der Flier, Wiesje M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465066/ https://www.ncbi.nlm.nih.gov/pubmed/30555032 http://dx.doi.org/10.1016/j.jalz.2018.10.003 |
Ejemplares similares
-
Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples
por: Wolfsgruber, Steffen, et al.
Publicado: (2019) -
Computer-assisted prediction of clinical progression in the earliest stages of AD
por: Rhodius-Meester, Hanneke F.M., et al.
Publicado: (2018) -
Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics
por: Song, Fei, et al.
Publicado: (2014) -
Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Cacciamani, Federica, et al.
Publicado: (2021) -
Upregulation of Glycolytic Enzymes, Mitochondrial Dysfunction and Increased Cytotoxicity in Glial Cells Treated with Alzheimer’s Disease Plasma
por: Jayasena, Tharusha, et al.
Publicado: (2015)